Heron Therapeutics, Inc.HRTXNASDAQ
LOADING
|||
Cash Generation Expanding
Trending higher, above historical average, structural decline.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-24.23M
↑ 82% above average
Average (9y)
$-135.37M
Historical baseline
Range
High:$-24.23M
Low:$-206.38M
CAGR
-12.4%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2024 | $-24.23M | +59.8% |
| 2023 | $-60.33M | +59.4% |
| 2022 | $-148.74M | +27.9% |
| 2021 | $-206.38M | -7.7% |
| 2020 | $-191.63M | -45.5% |
| 2019 | $-131.73M | +34.5% |
| 2018 | $-200.98M | -16.3% |
| 2017 | $-172.85M | -26.0% |
| 2016 | $-137.23M | -72.4% |
| 2015 | $-79.61M | - |